rivaroxaban - General Practice notebook
PDF) A protocol for DUAL pathway inhibition (low-dose rivaroxaban and aspirin) as compared to aspirin only to improve endothelial function in peripheral artery disease
Frontiers | Differential Inhibition of Platelet Reactivity by Dual Therapy With Aspirin and Low-Dose Rivaroxaban in Peripheral Arterial Disease: A Pilot Study
Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients - Vascular News
New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition - ScienceDirect
Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial | Journal of the American College of Cardiology
Rivaroxaban in Peripheral Artery Disease after Revascularization | NEJM
Xarelto Vascular Filmtabletten 2.5mg Dose 100 Stück in der Adler Apotheke
Efficacy Profile - Chronic CAD/PAD | XARELTO® (rivaroxaban) HCP
Xarelto® - Dosing Guide
FDA Clears Rivaroxaban to Reduce the Risk of Major Cardiovascular Events | DAIC
Xarelto Full Prescribing Information, Dosage & Side Effects | MIMS Philippines
Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios | SpringerLink
Apixaban may be safer for older patients with AF vs. rivaroxaban
Bayer announces new licensed indication for Xarelto in patients with CAD
Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers,Diabetologia - X-MOL
Dose Regimens in Approved Rivaroxaban Indications. 1 | Download Table
New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition with XARELTO Plus Aspirin in Patients with Coronary Artery Disease, Peripheral Artery Disease | DAIC
Low dose NOAC plus aspirin improves outcomes in stable CV disease compared to aspirin alone - PACE-CME
Xarelto® - Dosing Guide
Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial | Journal of the American College of Cardiology
Xarelto Vascular Filmtabletten 2.5mg Dose 100 Stück in der Adler Apotheke
Improved Dosing and Administration of Rivaroxaban when Prescribed by a Cardiologist | touchCARDIO
